Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|July 28, 2022
[MUC16: The Novel Target for Tumor Therapy]Ruyun Gao, Ning Lou, Xiaohong Han, et al.
BMC Cancer|November 26, 2024
Evaluating plasma antinuclear autoantibody profile as a prognostic biomarker in lymphomaCuiling Zheng, Ruyun Gao, Yanrong Wang, et al.
Scientific Data|December 18, 2024
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKINing Lou, Ruyun Gao, Yuankai Shi, et al.
Cell Death & Disease|November 6, 2024
DKK1+ tumor cells inhibited the infiltration of CCL19+ fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinomaGuangyu Fan, Ruyun Gao, Tongji Xie, et al.
Molecules (Basel, Switzerland)|October 27, 2022
Formation Optimization, Characterization and Antioxidant Activity of Auricularia auricula-judae Polysaccharide Nanoparticles Obtained via Antisolvent PrecipitationYemei Dai, Yuan Ma, Xiaocui Liu, et al.
Chinese Medical Journal|February 25, 2026
Epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of non-small cell lung cancer in the past 30 years (1997-2026)Zucheng Xie, Xinrui Chen, Ruyun Gao, et al.
Journal for Immunotherapy of Cancer|April 8, 2025
JAK3 A573V and JAK3 M511I mutations in peripheral T-cell lymphoma mediating resistance to anti-PD-1 therapy through the STAT3/PD-L1 pathwayNing Lou, Mengwei Yang, Zucheng Xie, et al.
Science China. Life Sciences|May 15, 2025
Single-cell sequencing and spatial transcriptomics reveal FAS+ T cell and autophagy-related signatures predicting chemoimmunotherapy response in diffuse large B-cell lymphoma patientsNing Lou, Liyuan Dai, Ruyun Gao, et al.
Journal of Translational Medicine|June 18, 2024
Mutational variant allele frequency profile as a biomarker of response to immune checkpoint blockade in non-small cell lung CancerRuyun Gao, Ning Lou, Lin Li, et al.
Expert Review of Vaccines|October 25, 2023
Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccinationRuyun Gao, Cuiling Zheng, Mengwei Yang, et al.
Pageof 2